WuXi Biologics (Cayman) I... (WXXWY)
Company Description
WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally.
The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities.
WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc.
The company was incorporated in 2014 and is headquartered in Wuxi, China.

Country | CN |
IPO Date | Dec 18, 2017 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 12,575 |
CEO | Dr. Zhisheng Chen Ph.D. |
Contact Details
Address: No. 108, Meiliang Road Wuxi, CN | |
Website | https://www.wuxibiologics.com |
Stock Details
Ticker Symbol | WXXWY |
Exchange | PNK |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | n/a |
CUSIP Number | 98260N108 |
ISIN Number | US98260N1081 |
Employer ID | - |
SIC Code | n/a |
Key Executives
Name | Position |
---|---|
Dr. Weichang Zhou Ph.D. | Honorary President of Global Biologics Development, Senior Advisor to Chief Executive Officer & Non-Executive Director |
Dr. Zhisheng Chen Ph.D. | Chief Executive Officer & Executive Director |
Dr. Sherry Gu Ph.D. | Chief Technology Officer and Executive Vice President of Global Biologics Development Department |
Lihua Yu M.B.A. | Chief Operating Officer & Senior Vice President |
Ming Tu | Chief Financial Officer & Executive Vice President |
Dr. Ge Li Ph.D. | Founder & Chairman |
Dr. Jijie Gu Ph.D. | Chief Scientific Officer & President of Global Biologics Research |
He Wang | Chief Compliance Officer, Senior Vice President and Head of Global Compliance & Risk Management |
Li Xiong | Vice President & Head of Global Human Resources |
Lina Fan Ph.D. | Senior Vice President & Head of Investor Relations |